Genotyping
Botucatu · Founded 2008
About Genotyping
Genotyping brings precision medicine to consumers through genetic diagnosis using next-generation sequencing technology. Genotyping is a Brazilian biotechnology company founded in 2008 by UNESP researchers together with entrepreneurs. In 2013, the company expanded its operations to the molecular diagnostics industry, pioneering the next-generation sequencing to use for genetic analysis. Located in Botucatu, it has a modern laboratory with operating license that is FDA approved, has qualified and personalized customer service. The company has scientific and technical body able to perform a full range of molecular analysis of the human genome, enabling the development of new tests to meet specific customer needs. The company provides genetic panels that assess multiple genes in a single analysis, enabling physicians to offer patients the latest diagnosis associated with prevention.
Company Facts
- Founded: 2008
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2015)
- Website: http://genotyping.com.br/
- Phone: (14) 3813-5094
Industries & Categories
Biotechnology, Genetics, Health Diagnostics, Life Science, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/genotyping-2890290 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.